SOW.docx

DOCX document 28 KB Posted

Attached to
6550-- Cancer Diagnosis Probes
Solicitation number
36C26225Q0840
Issued by

About this file

This Statement of Work (SOW) details the procurement of specialized FISH probes and reagents for the VA Greater Los Angeles Healthcare System's cytogenetics department. The document outlines requirements for next-generation sequence testing, specifically requesting probes and reagents for diagnosing various cancer types including Myeloproliferative Neoplasms, Myelodysplasia, Acute Myeloid Leukemia, Lymphoid Malignancies, and Solid Tumors. The procurement involves a comprehensive list of 37 specific genetic probe products for human testing, with each probe designed to identify specific genetic mutations or chromosomal abnormalities, packaged in 100µl volumes.

The solicitation is for the Desert Pacific Healthcare Network (VISN 22) and will be processed through the VA Greater Los Angeles Healthcare System located at 11301 Wilshire Blvd, CA 90073. The contract includes specific operational requirements, such as operating 24/7 with normal duty hours from 6:00 am to 2:30 pm Monday through Friday, excluding federal holidays. Strict information security protocols are mandated, including background investigations for all contractor personnel accessing VA computer systems, with compliance required with federal information security regulations such as FISMA and NIST standards. The solicitation number is 36C26225Q0840, and the procurement is being conducted by the Department of Veterans Affairs Veterans Health Administration.

View the file

Other files

File Type Posted
36C26225Q0840.docx DOCX document
Attachment A.xlsx XLSX spreadsheet
RFQ.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Statement of Work- Greater Los Angeles Healthcare System Cancer Diagnosis Probes & Reagents

1. Introduction

The purpose of this Statement of Work (SOW) is to outline the tasks and responsibilities of the successful offeror in relation to the VA Greater Los Angeles Healthcare System for next generation sequence testing.

1.1 Background

The VAGLAHS at 11301 Wilshire Blvd, CA 90073 is part of the Desert Pacific Healthcare Network (VISN 22), and is one of the most diversified tertiary health care providers in the VA. It is a teaching hospital, providing a full range of patient services, with state-of-the art technology as well as education and research. It also boosts one of the largest and most diverse patient populations in the VA system.

The section has become a reference lab for other facilities within VISN 22 for cytogenetics testing. This has allowed VISN 22 to benefit from reduced cost of send outs as well as improved turnaround time. To maintain the in-house laboratory, the cytogenetics department requires the use of specific probes and reagents utilized for testing. The specific material is essential to continued function as they have been validated, which is a requirement for initial use and ongoing testing. Due to the cost and volume of the reagents and supplies needed an annual PO is most efficient for ordering purposes. It would be utilized as needed, based on the samples sent to the department for testing.

2. Scope

Obtain reagents and consumables that are equal to or equivalent with MetaSystems FISH probes and reagents for hematological disorders.

Characteristics:

· Pre-mixed, eliminating the laborious and time-consuming steps of measuring and mixing probes daily. compatible

· Require only 2 hours for hybridization.

The information identified provided is intended to be descriptive, not restrictive and to indicate the quality that will be satisfactory. The interested parties bear full responsibility to ensure their submission demonstrates to the government that they can provide the brand name or equal to supplies being requested.

Must include the following Genes:

Myeloproliferative Neoplasms: BCR-ABL1, PDGFRA, PDGFRB, FGFR1, CBFB

Myelodysplasia: EGR1, D7, CEP8, D20

Acute Myeloid Leukemia: RUNX1T1-RUNX1, PML-RARA, CBFB, KMT2A, BCR-ABL1, EVI1, TP53, DEK-NUP214

Lymphoid Malignancies: D13, ATM, P53, CEP12, IGH, CKS1B, IGH-CCND1, IGH-CCND3, IGH-FGFR3, IGH-MAF, IGH-MAFB, BCR-ABL1, MLL, MYC, IGH-BCL2, IGH-MYC, MALT1, BCL6, BCL2

Solid Tumor: CEN3/7/17/CDKN2C, HER2, ALK, ROS1, RET, MET, NTRK1

Products Required to meet these needs:

Description
Name
Species
Conc
Type
Vol
1p32 (CDKN2C) + 1q21 (CKS1B)
XL CDKN2C/CKS1B
Human
1x
Deletion
100µl
2p23 (ALK) Tissue Qualified
CL 2p23 ALK BA
Human
1x
Break Apart
100µl
3q26 (MECOM (MDS1 EVI1 Complex)
XL MECOM
Human
1x
Break Apart,Inv
100µl
3q27 (BCL6) Tissue Qualified
XL BCL6 BA
Human
1x
Break Apart
100µl
4q12 FIP1L1 + CHIC2 + PDGFRA 3-color
XL 4q12
Human
1x
Del/Fusion
100µl
5q31 (EGR1) + 5p15
XL del (5)(q31)
Human
1x
Deletion
100µl
5q32 (PDGFRB)
XL 5q32 PDGFRB
Human
1x
Break Apart
100µl
6q22 (ROS1) Tissue Qualified
XL ROS1-GOPC BA
Human
1x
Break Apart
100µl
6p22 (DEK) + 9q34 (NUP214)
XL t(6;9) DEK/NUP214
Human
1x
Dual Fusion
100µl
7q31 (D7S486) + 7cen
CL 7q31(D7S486)
Human
1x
Deletion
100µl
7q31 (MET) + 7cen Tissue Qualified
XL MET amp
Human
1x
Amplification
100µl
8p11 (FGFR1)
XL FGFR1
Human
1x
Break Apart
100µl
8q22 (RUNX1T1 (ETO)) + 21q22 (RUNX1 (AML1))
CL RUNX1T1/RUNX1
Human
1x
Dual Fusion
100µl
8q24 (MYC) BA Tissue Qualified
XL MYC BA
Human
1x
Break Apart
100µl
9q34 (ABL1) + 22q11 (BCR), (t9;22)
XL BCR/ABL1 plus
Human
1x
Dual Fusion
100µl
10q11 (RET) BA Tissue Qualified
XL RET BA
Human
1x
Break Apart
100µl
11q22 (ATM) + 17p13 (TP53)
XL ATM/TP53
Human
1x
Deletion
100µl
11q23 (KMT2A (MLL)) BA Covers
XL KMT2A BA
Human
1x
Break Apart,Inv
100µl
13q14 (DLEU) + 13q34 (LAMP)
XL DLEU/LAMP
Human
1x
Deletion
100µl
13q14 (DLEU) + 13q34 (LAMP) + 12cen
XL DLEU/LAMP/12cen
Human
1x
Deletion
100µl
14q32 (IGH)
XL IGH
Human
1x
Break Apart,Inv
100µl
14q32 (IGH) + 4q16 (FGFR3)
XL t(4;14) FGFR3/IGH DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 6p21 (CCND3) covers gene
XL CCND3/IGH DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 8q24 (MYC)
XL t(8;14) MYC/IGH DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 11q13 (CCND1)
XL t(11;14) CCND1/IGH DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 16q23 (MAF/WWOX)
XL t(14;16) IGH/MAF DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 18q21.33 (BCL2)
XL t(14;18) IGH/BCL2 DF
Human
1x
Dual Fusion
100µl
14q32 (IGH) + 20q12 (MAFB covered), t(14;20)
XL IGH/MAFB DF
Human
1x
Dual Fusion
100µl
15q24 (PML) + 17q21 (RARA) Dual Fusion
XL t(15;17)
Human
1x
Dual Fusion
100µl
16q22 (CBFB)
XL CBFB
Human
1x
Break Apart
100µl
17q12 (ERBB2 (HER2/NEU)) + 17cen Tissue Qualified
XL ERBB2 (HER2/NEU)
Human
1x
Amplification
100µl
17p13 (TP53) + D17Z1 (17Cen)
XL TP53/17cen
Human
1x
Deletion
100µl
18q21 (BCL2) Tissue Qualified
XL BCL2 BA
Human
1x
Break Apart
100µl
18q21 (MALT) Tissue Qualified
XL MALT1 BA
Human
1x
Break Apart
100µl
20q12 (PTPRT) + 20qter + 8Cen
XL 20q12/20qter/8cen plus
Human
1x
Deletion
100µl
DAPI/Antifade (100 x 500ul) Bulk Pk
DAPI/Antifade
N/A
250ng/ml
Counterstain
100 x 500µl
Tissue Pre-treatment @ 5+ kits
Tissue Pre-treatment
N/A
N/A
Pre-treatment
5+ x (4-20 slides)

3. Hours of Operation

· Normal tour-of-duty hours at VAGLAHS is 6:00 am to 2:30 pm, Monday through Friday, excluding Federal holidays. However, the service is operating 24/7 and as such there may be instances in which the vendor’s workday may be outside of this period. The vendor is required to coordinate these times with the designated Program Manager.

· In accordance with 5 U.S.C. 6103, Executive Order 11582 and Public Law 94-97 the following national holidays are observed and for the purpose of this contract are defined as “Legal Federal official holidays”

New Year’s Day
January 1st
Martin Luther King’s Birthday
Third Monday in January
President’s Day
Last Monday in January
Memorial Day
Last Monday in January
Independence Day
July 4th
Labor Day
First Monday in September
Columbus Day
Second Monday in October
Veteran’s Day
November 11th
Thanksgiving Day
Fourth Thursday in November
Christmas Day
December 25th

When a holiday falls on a Sunday, the following Monday will be observed as a National Holiday. When a holiday falls on a Saturday, the preceding Friday is observed as a National Holiday by U.S. Government Agencies.

4. Security

4.1 Information Security

· The vendor shall ensure adequate LAN/Internet, data, information, and system security in accordance with VA standard operating procedures and standard contract language, conditions laws, and regulations. The vendor’s firewall and web server shall meet or exceed the government minimum requirements for security. All government data shall be protected behind an approved firewall. Any security violations or attempted violations shall be reported to the VA Project Manager and the VBA Headquarters Information Security Officer as soon as possible. The vendor shall follow all applicable VA policies and procedures governing information security, especially those that pertain to certification accreditation.

(a) The contractor and their personnel shall be subject to the same Federal laws, regulations, standards and VA policies as VA personnel, regarding information and information system security. These include, but are not limited to Federal Information Security Management Act (FISMA), Appendix III of OMB Circular A-130, and guidance and standards, available from the Department of Commerce's National Institute of Standards and Technology (NIST). This also includes the use of common security configurations available from NIST's Web site at: http://checklists.nist.gov

(b) To ensure that appropriate security controls are in place, Contractors must follow the procedures set forth in "VA Information and Information System Security/Privacy Requirements for IT Contracts" located at the following Web site: http://www.iprm.oit.va.gov

4.2 Contract Personnel Security

All contractor employees who require access to the Department of Veterans Affairs' computer systems shall be the subject of a background investigation and must receive a favorable adjudication from the VA Security and Investigations Center (07C). The level of background security investigation will be in accordance with VA Directive 0710 dated September 10, 2004 and is available at: http://www.va.gov/pubs/asp/edsdirec.asp (VA Handbook 0710, Appendix A, Tables 1 - 3). Appropriate Background Investigation (BI) forms will be provided upon contract (or task order) award, and are to be completed and returned to the VA Security and Investigations Center (07C) within 30 days for processing. Contractors will be notified by 07C when the BI has been completed and adjudicated. These requirements are applicable to all subcontractor personnel requiring the same access. If the security clearance investigation is not completed prior to the start date of the contract, the employee may work on the contract while the security clearance is being processed, but the contractor will be responsible for the actions of those individuals they provide to perform work for the VA. In the event that damage arises from work performed by contractor personnel, under the auspices of the contract, the contractor will be responsible for resources necessary to remedy the incident.

File details come from the government source that posted it. Updated .